Early sublingual immunotherapy for allergic rhinitis reduces risks for allergic asthma

Children who begin sublingual immunotherapy for allergic rhinitis at age 5 years have less risk for developing allergic asthma than children who begin this treatment later, according to a study published in Allergy.
Early initiation also improves quality of life and reduces health care costs, Eckard Hamelmann, MD, PhD, chief physician, Clinic for Pediatric and Adolescent Medicine, Bethel Children’s Center, Evangelical Hospital, Bielefeld, Germany, and colleagues wrote.
“It has been shown in multiple clinical studies that allergy immunotherapy (AIT), not surprisingly, works well and

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart